Baird Medical Investment Holdings Lists on Nasdaq
Baird Medical Investment Holdings Ltd. (BDMD) (“Baird Medical” or the “Company”), a leading microwave ablation (“MWA”) medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced a successful listing in the
“Becoming a public company in
The Nasdaq listing comes as the Company expands its footprint in the U.S. market following recent FDA clearance for its minimally invasive microwave ablation technology, which offers a promising alternative to thyroidectomy for patients with benign thyroid tumors. Currently, 150,000 thyroidectomies are performed in the U.S. annually.